CEFTAZIDIME - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for ceftazidime and what is the scope of patent protection?

Ceftazidime is the generic ingredient in ten branded drugs marketed by Acs Dobfar, Aurobindo Pharma Ltd, Wockhardt, B Braun, Glaxosmithkline, Pai Holdings Pharm, Hospira, Lilly, and Baxter Hlthcare, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for ceftazidime. Three suppliers are listed for this compound.

Summary for CEFTAZIDIME

US Patents:	0
Tradenames:	10
Applicants:	9
NDAs:	16
Drug Master File Entries:	17
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	42
Clinical Trials:	68
Patent Applications:	7,033
What excipients (inactive ingredients) are in CEFTAZIDIME?	CEFTAZIDIME excipients list
DailyMed Link:	CEFTAZIDIME at DailyMed

Recent Clinical Trials for CEFTAZIDIME

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Tata Memorial Centre	Phase 2
Qianfoshan Hospital	N/A
Arrevus Inc.	Phase 2

See all CEFTAZIDIME clinical trials

Pharmacology for CEFTAZIDIME

Drug Class	Cephalosporin Antibacterial

Medical Subject Heading (MeSH) Categories for CEFTAZIDIME

Anti-Bacterial Agents

Anatomical Therapeutic Chemical (ATC) Classes for CEFTAZIDIME

J01DD	Third-generation cephalosporins
J01D	OTHER BETA-LACTAM ANTIBACTERIALS
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J	Antiinfectives for systemic use

US Patents and Regulatory Information for CEFTAZIDIME

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pai Holdings Pharm	FORTAZ IN PLASTIC CONTAINER	ceftazidime sodium	INJECTABLE;INJECTION	050634-003	Apr 28, 1989		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Glaxosmithkline	CEPTAZ	ceftazidime	INJECTABLE;INJECTION	050646-003	Sep 27, 1990		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Lilly	TAZIDIME IN PLASTIC CONTAINER	ceftazidime	INJECTABLE;INJECTION	062739-002	Jul 10, 1986		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.